Alto Neuroscience, Inc. · NYSE:ANRO
Point72 Asset Management, L.P. reported a 8.90% stake in Alto Neuroscience, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Point72 Asset Management, L.P. reported a 8.90% stake in Alto Neuroscience, Inc., 2,824,275 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 8.90%
- Shares
- 2,824,275
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 6.80% | 2,156,497 |
| Point72 Capital Advisors, Inc. | 6.80% | 2,156,497 |
| Point72 Biotech Private Investments, LLC | 2.10% | 667,778 |
| Differentiated Ventures Investments, LLC | 2.10% | 667,778 |
| 72 Investment Holdings, LLC | 2.10% | 667,778 |
| Steven A. Cohen | 8.90% | 2,824,275 |
Source
Related
- Alto Neuroscience, Inc.
- Point72 Asset Management, L.P.
- Alto Neuroscience, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2025
- Schedule 13G/A · Point72 Asset Management, L.P. · Feb 14, 2025
- Form 4 · Smith Nicholas Conrad · Oct 5, 2026
- Form 4 · Smith Nicholas Conrad · Oct 1, 2026
- Schedule 13G/A · Vestal Point Capital, LP · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026